Industries > Pharma > Global Bioactive Wound Care Market Forecasts 2017-2027

Global Bioactive Wound Care Market Forecasts 2017-2027

Biological Wound Care, Moist Wound Care and Antimicrobial Wound Care

PUBLISHED: 23 January 2017
PAGES: 213
PRODUCT CODE: PHA0163

Clear
WOOCS 2.2.1
SKU: PHA0163 Categories: , , , Tag:

The global bioactive wound care market is expected to grow at a CAGR of 8.7% in the first half of the forecast period and CAGR of 7.5% in the second half of the forecast period. The market is expected to grow at a CAGR of 8.0% from 2017 to 2027. The market is estimated at $4,825 million in 2016, $8,052 million in 2021, and $12,420 million in 2027.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 213-page report you will receive 100 tables and 103 figures– all unavailable elsewhere.

The 213-page report provides clear detailed insight into the global bioactive wound care market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Global Bioactive Wound Care Market Forecasts 2017-2027

Report Scope

Global Bioactive Wound Care Market forecasts from 2017-2027

Moist Wound Care submarket forecasts from 2017-2027, further segmented into:
– Alginate Dressings
– Hydrocolloid Dressings

This section also discusses the leading product as well as SWOT analysis of this submarket.

Biological Wound Care submarket forecasts from 2017-2027, further segmented into:
– Skin Substitutes
– Collagen Dressings
– Cell Based Therapy
– Others

This section also discusses the leading product as well as SWOT analysis of this submarket.

Antimicrobial Wound Care submarket forecasts from 2017-2027, further segmented into:
– Silver-Based
– Iodine-Based
– Chitosan-Based
– Others

This section also discusses the leading product as well as SWOT analysis of this submarket.

• Bioactive Wound Care Leading Regional Market forecasts from 2017-2027 covering North America, Western Europe, Eastern Europe, Asia-Pacific, Latin America, Middle East and Africa.

Each region is further segmented into the submarkets of moist wound care, biological wound care and antimicrobial wound care.

• Bioactive Wound Care forecasts by country from 2017-2027, covering:
– United States
– Canada
– Germany
– France
– United Kingdom
– Italy
– Spain
– Russia
– Poland
– China
– South Korea
– Japan
– India
– Australia
– New Zealand
– Brazil
– Mexico
– Saudi Arabia
– Turkey
– Israel
– South Africa

• Assessment of selected leading companies that hold major market shares in the bioactive wound care market.

Visiongain’s study is intended for anyone requiring commercial analyses for the Bioactive Wound Care Market. You find data, trends and predictions.

Buy our report today Global Bioactive Wound Care Market Forecasts 2017-2027: Biological Wound Care, Moist Wound Care and Antimicrobial Wound Care.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Bioactive Wound Care Market Forecasts 2017-2027


Download sample pages

Complete the form below to download your free sample pages for Global Bioactive Wound Care Market Forecasts 2017-2027


Latest Pharma news

Visiongain Publishes Plasma Therapy Market Report 2021-2031

The market is forecasted for the next ten years based on market growth within each segment of the blood plasma products. The report study aims to explore the market drivers, restraints and also market opportunities facing blood plasma product stakeholders in different geographic areas.

26 November 2020

READ

Visiongain Publishes Precision Cancer Diagnostic Test Market Report 2021-2031

Molecular diagnostics are rapidly transforming drug development and patient selection: trials with biomarkers have higher success rates than those without, and combining patients with a proven biomarker allows efficient trials to be conducted in rare cancers.

26 November 2020

READ

Visiongain Publishes Top 50 Biosimilar Drug Manufacturers 2021

Growing demand for cost-effective drugs; rising prevalence of chronic diseases; mounting investment in drug R&D by biopharmaceutical companies; new product launches and rising acceptance of biosimilars in North America region are some of the major factors that propel the biosimilars market growth.

25 November 2020

READ

Visiongain Publishes Advanced Therapy Medicinal Products (ATMP) Market Report 2021-2031

Currently, the ATMP market is at a nascent stage and is expected to flourish during near future owing to increasing research and development activities and rising use of ATMP therapy products in treatment areas with low or no alternative treatment options support the market growth

24 November 2020

READ

Categories